Where to buy MOTS-c in the UK: the sellers with a verifiable COA
The newest verifiable MOTS-c certificate on any UK seller's website is on Lab77Peptides (lab77peptides.uk), analysed 23 Oct 2026 (task #244128 on Janoshik's site); 15 verified sellers hold one covering MOTS-c, listed newest first below.
Who holds the newest MOTS-c report (15 verified UK sellers)
| Seller | Newest MOTS-c report | Age of that report | |
|---|---|---|---|
| Lab77Peptides lab77peptides.uk | 23 Oct 2026 | 30 days | verify |
| Mercia Research merciaresearch.com | 18 Sep 2026 | 2 months, 4 days | verify |
| Pureline Biolabs purelinebiolabs.co.uk | 22 Jul 2026 | 4 months | verify |
| Biohacklondon biohacklondon.com | 19 Jun 2026 | 5 months, 3 days | verify |
| Reta24 reta24.co.uk | 25 May 2026 | 5 months, 28 days | verify |
| Thoroughbredlabs thoroughbredlabs.co.uk | 15 May 2026 | 6 months, 7 days | verify |
| Phoenixbiolabs phoenixbiolabs.net | 13 May 2026 | 6 months, 9 days | verify |
| Camo Chem camochem.uk | 7 May 2026 | 6 months, 15 days | verify |
| Kensingtonlabs kensingtonlabs.co.uk | 5 May 2026 | 6 months, 17 days | verify |
| MyoTech myotech.co | 5 May 2026 | 6 months, 17 days | verify |
| Ascendpeptidesuk ascendpeptidesuk.com | 7 Apr 2026 | 7 months, 15 days | verify |
| Regenix Peptides regenix-peptides.co.uk | 24 Mar 2026 | 7 months, 29 days | verify |
| Imperialpeptides imperialpeptides.co.uk | 5 Feb 2026 | 9 months, 17 days | verify |
| Clinicore clinicore.co.uk | 26 Jan 2026 | 9 months, 27 days | verify |
| Xlpeptides xlpeptides.com | 13 Nov 2025 | 12 months, 9 days | verify |
Newest report first. Every report was opened on Janoshik's own website and names the seller as the client. The date is the analysis date printed on the report. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
A record of paperwork, not a recommendation: The Peptide Watch sells nothing, takes no money from sellers and links to none of them.
Why the date matters · What purity means · What MOTS-c is · Regulators · Every report
Every MOTS-c purity report we have read (18), one row per report
The 18 verifiable MOTS-c certificates we have read, newest first
Each row was opened on Janoshik's own site by a real page load and transcribed. The client column is the name the laboratory printed; a certificate counts as a seller's own only when that name is the seller. The report date is the analysis date printed on the report where we have read it, otherwise the date the laboratory received the sample. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
| Seller | Task | Client on the report | Report date | Result | Batch | |
|---|---|---|---|---|---|---|
| Lab77Peptides | #244128 | Lab77peptides.uk | 23 Oct 2026 | MOTS-c · 10.57 mg · 99.130% | L77Mot27 | verify |
| Mercia Research | #231804 | Mercia Research Limited | 18 Sep 2026 | MOTS-c · 6.86 mg/ml · 98.770% | MRL-26Q3-A06 | verify |
| Pureline Biolabs | #209942 | Pureline Biolabs Ltd | 22 Jul 2026 | MOTS-c · 11.23 mg · 98.123% | PLB-008 | verify |
| Biohacklondon | #168534 | BioHack London Ltd | 19 Jun 2026 | MOTS-c · 46.46 mg · 99.234% | 2026-06 | verify |
| Biohacklondon | #168644 | BioHack London Ltd | 19 Jun 2026 | MOTS-c · 11.87 mg · 99.027% | 2026-06 | verify |
| Lab77Peptides | #193656 | Lab77Peptides.co.uk | 19 Jun 2026 | MOTS-C · 9.86 mg · 98.755% | 77MTC265 | verify |
| Reta24 | #135272 | Reta24 whatsapp +31 6 26255122 | 25 May 2026 | MOTS-c · 41.28 mg · 99.152% | 241 | verify |
| Thoroughbredlabs | #149085 | Thoroughbred Labs | [email protected] | 15 May 2026 | MOTS-c · 43.25 mg · 98.846% | TBLMO112 | verify |
| Thoroughbredlabs | #149086 | Thoroughbred Labs | [email protected] | 15 May 2026 | MOTS-c · 10.89 mg · 98.741% | TBLMO143 | verify |
| Phoenixbiolabs | #147250 | www.phoenixbiolabs.net | 13 May 2026 | MOTS-c · 10.51 mg · 98.689% | Batch-0101 used in vials + pen(s) | verify |
| Camo Chem | #150732 | Camo Chem UK | 7 May 2026 | MOTS-C · 10.35 mg · 99.016% | 200-EU | verify |
| Kensingtonlabs | #121938 | Kensington Labs | 5 May 2026 | MOTS-c · 10.73 mg · 99.244% | MOT-745MF | verify |
| MyoTech | #150961 | Myotech | 5 May 2026 | MOTS-c · 10.73 mg · 99.244% | MOT-745MF | verify |
| Ascendpeptidesuk | #125392 | Ascend Peptides UK | 7 Apr 2026 | MOTS-c · 43.66 mg · 99.391% | 20260114 | verify |
| Regenix Peptides | #121867 | https://www.regenix-peptides.co.uk | 24 Mar 2026 | MOTS-c · 41.79 mg · 99.200% | MOTS401 | verify |
| Imperialpeptides | #105938 | Imperial Peptides UK | www.imperialpeptides.co.uk | 5 Feb 2026 | MOTS-c · 10.96 mg · 99.041% | MOT10-12/27 | verify |
| Clinicore | #102607 | clinicore | 26 Jan 2026 | MOTS-C · 23.12 mg · 99.361% | MO20101 | verify |
| Xlpeptides | #88425 | XL Peptides | 13 Nov 2025 | MOTS-c · 10.09 mg · 96.819% | 0Z3A0 | verify |
Why the date on a certificate matters
What a purity figure means
The purity on a Janoshik report is the share of the main peak in an HPLC chromatogram. 99.5% means that 99.5% of what the detector saw was one substance and 0.5% was something else. It is not the amount in the vial: that is the separate quantity line, in milligrams. It does not by itself prove which substance the peak is: that is identity, confirmed by mass spectrometry. And it says nothing about sterility, endotoxins or heavy metals, which are separate tests.
A purity figure printed on a shop page with no report behind it is a claim, not a measurement. Between two reports, the difference that matters is rarely 99.2% against 99.8%; it is whether the report exists at all, names the seller as the client, covers this compound on its own, and is recent.
What MOTS-c is, and what it is sold as
MOTS-c is a mitochondrial-derived peptide studied in metabolic research. It is a newer, less commoditised compound, so genuinely independent testing is scarcer and a verifiable certificate matters even more.
| Development status | Development abandoned. CohBar stopped its analogue CB4211 after phase 1a/1b and merged; no other sponsor has a drug programme. |
|---|---|
| Originator | Discovered as a mitochondrial-derived peptide; the only drug candidate, CB4211, was CohBar's analogue. Rights: No active rights holder or developer. CohBar suspended CB4211 and merged. |
| Registered clinical trials | 6 on ClinicalTrials.gov |
A real human peptide with a mostly preclinical record. MOTS-c is encoded in mitochondrial DNA. PubMed indexes 255 papers, 92 of them rat or mouse studies; the 5 papers indexed as clinical trials are small, and 4 of the 6 registered studies on ClinicalTrials.gov have no drug phase at all.
The one drug programme was abandoned. CohBar took an analogue, CB4211, through a phase 1a/1b study in fatty liver disease and obesity, reported in 2021, then said the formulation was not suitable for further development and suspended the programme before merging. No company is developing MOTS-c today.
What that means for a buyer. No human dose, effect or safety profile has been established for MOTS-c as sold, so the certificate is the only checkable fact about a vial.
The published record in numbers, and the sources
| Papers on PubMed | 255 |
|---|---|
| Indexed as rat or mouse studies | 92 |
| Indexed as clinical trials | 5 |
| Published since 2020 | 217 |
Counts are from PubMed on 15 September 2026 using the queries recorded in our evidence file. A description of the published record, not medical advice and not an argument for or against use.
- Repeated Heat Stress Modulates the Levels of the Mitokines MOTS-C and FGF21 in Active Men during Calf Muscle Immobilization. (Med Sci Sports Exerc, 2025, PMID 40674654)
- Circulating levels of MOTS-c in patients with breast cancer treated with metformin. (Aging (Albany NY), 2022, PMID 36490309)
- Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans. (J Appl Physiol (1985), 2021, PMID 34351816)
- Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic White breast cancer survivors. (Sci Rep, 2021, PMID 34413391)
- MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. (Front Endocrinol (Lausanne), 2023, PMID 36761202)
- Mitochondrial-derived peptides and exercise. (Biochim Biophys Acta Gen Subj, 2021, PMID 34520826)
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. (Sports Med, 2026, PMID 41966639)
- BioSpace, CohBar update on the CB4211 phase 1a/1b trial
- CohBar, SEC filing on the merger and legacy assets (2023)
What regulators say about MOTS-c
In the UK. Not a licensed medicine in the UK. Sold as a research chemical.
We hold no statement from the FDA, MHRA or EMA specifically about MOTS-c on file. Its development and licence sources are listed under the record above.
What the 18 MOTS-c certificates show
We have read 18 Janoshik reports covering MOTS-c, published by 15 UK sellers. Each was opened on Janoshik's own website. All 18 name the seller itself as the client. 7 of the 18 are dated within the last six months and 1 is more than a year old. The newest is dated 23 Oct 2026 and the oldest 13 Nov 2025.
All 18 reports give a purity figure for MOTS-c. The figures run from 96.819% to 99.391%, and 11 of the 18 are at 99% or above. A purity figure describes the sample the laboratory received, not every vial from that batch.
Read directly from the newest reports: Lab77Peptides: task #244128, analysed 23 Oct 2026, 10.57 mg recovered at 99.130%, client Lab77peptides.uk; Mercia Research: task #231804, analysed 18 Sep 2026, 6.86 mg/ml at 98.770%, client Mercia Research Limited; Pureline Biolabs: task #209942, sample received 22 Jul 2026, 11.23 mg recovered at 98.123%, client Pureline Biolabs Ltd.
A certificate is a batch document. The lines that matter are the compound (it must say MOTS-c, not only a batch code), the client (the shop, not its supplier) and the analysis date. A new batch is untested until a new report appears.
MOTS-c in the UK at a glance
| Active UK sellers listing MOTS-c | 96 |
|---|---|
| Of which publish a verifiable own-name certificate | 17 |
| Of which name no laboratory at all | 15 |
Counted from the vendor ledger at build time. The A-Z directory lists every seller and what each publishes instead.
Questions people ask
Which UK sellers publish a verifiable Janoshik certificate naming MOTS-c?
As of 22 November 2026, 15: Lab77Peptides, Mercia Research, Pureline Biolabs, Biohacklondon, Reta24, Thoroughbredlabs, Phoenixbiolabs, Camo Chem, Kensingtonlabs, MyoTech, Ascendpeptidesuk, Regenix Peptides, Imperialpeptides, Clinicore, Xlpeptides. Each has a report on Janoshik's own website that names the seller as the client and lists MOTS-c. That is a statement about paperwork, not a recommendation; The Peptide Watch does not recommend anywhere to buy MOTS-c.
How recent is the newest MOTS-c certificate from a UK seller?
The newest we have read is Janoshik task #244128, analysed 23 Oct 2026. It is published by Lab77Peptides and names it as the client. A certificate covers one batch, so an old one says little about stock on sale today.
How do I check that a certificate for MOTS-c is genuine?
Four things: an independent laboratory is named; the client field names the seller you are buying from, not a supplier; the compound line says MOTS-c; and the report's task number and key open the same report on the laboratory's own website (verify.janoshik.com). A branded PDF with no laboratory name and no verification code fails on the first check, however professional it looks. The free COA Checker on this site runs the checks for you.
Is MOTS-c a licensed medicine in the UK?
Not a licensed medicine in the UK. Sold as a research chemical. CohBar stopped its analogue CB4211 after phase 1a/1b and merged; no other sponsor has a drug programme. The Peptide Watch does not give legal or medical advice.
Why does The Peptide Watch not say where to buy MOTS-c?
Because the site records paperwork, not recommendations. A verifiable certificate proves that a sample of one batch was tested. It does not prove the vial you receive matches it, and it says nothing about whether anyone should use MOTS-c. Listing which sellers publish a certificate you can check, and which publish nothing, is as far as the evidence goes.
The Peptide Watch's position on MOTS-c
Not a licensed medicine in the UK. Sold as a research chemical. The Peptide Watch reads the certificates UK sellers publish and does not recommend anywhere to buy MOTS-c. Sellers on this page are listed by the date of their newest MOTS-c certificate and by nothing else. If you can verify a seller's testing, you can at least judge its evidence; if you cannot, you are taking the seller's word for what is in the vial. See how UK testing compares across every seller in the market statistics.
An honest note: a verifiable certificate proves a sample of a batch was tested, not that the specific vial you receive matches it, see what this can and can't tell you. The Peptide Watch sells no MOTS-c and links to no shop; this is research-use-only information, not medical or dosing advice.
All peptides · Other compounds: BPC-157 · TB-500 · GHK-Cu · Ipamorelin · CJC-1295 · Epithalon · Selank · Semax · Tesamorelin · Melanotan 2 · KPV · PT-141 · SS-31 · DSIP · NAD+ · Melanotan 1 · AOD-9604 · 5-Amino-1MQ · Glutathione · Kisspeptin · Thymosin Alpha-1 · GHRP-6 · HGH Fragment 176-191 · IGF-1 LR3 · FOXO4-DRI · Oxytocin · SLU-PP-332 · MK-677 · GLOW and KLOW blends · Sermorelin · GHRP-2 · Hexarelin · ARA-290 · AHK-Cu